Protocolo terapéutico del hipertiroidismo

  1. Larrán Escandón, L.
  2. Gavilán, Inmaculada
  3. Cayón, Manuel
  4. Aguilar Diosdado, Manuel
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2012

Issue Title: Enfermedades endocrinológicas y metabólicas: patología del tiroides

Series: 11

Issue: 14

Pages: 849-853

Type: Article

DOI: 10.1016/S0304-5412(12)70395-5 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Hyperthyroidism is a clinical entity characterized by increased thyroid hormone production. The therapeutic approach differs according to the etiology, being the most common causes Graves' disease, toxic multinodular goiter and toxic adenoma; and according to patient characteristics. Antithyroid drugs (metimazole, carbirnazole) inhibit the formation of thyroid hormones, and they can be used as definitive treatment in Graves' disease or to achieve normal thyroid function prior to treatment with 1311 or surgery. Treatment with 1311 can be used as a treatment for hyperthyroidism, sometimes requiring repeated doses for cure, with the main side effect of hypothyroidism. Total thyroidectomy may be the treatment of choice for toxic multinodular goiter and Graves disease, requiring later levothyroxine replacement therapy, may be more conservative in the toxic adenoma with subtotal thyroidectomy.